A R Zanetti

Summary

Affiliation: University of Milan
Country: Italy

Publications

  1. doi request reprint Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy
    Alessandro Zanetti
    Dipartimento di Scienze Biomediche per la Salute, Universita degli Studi di Milano, Via Carlo Pascal, 36, 20133 Milano, Italy
    Vaccine 30:5770-5. 2012
  2. pmc Epidemiological and clinical features of rotavirus among children younger than 5 years of age hospitalized with acute gastroenteritis in Northern Italy
    Gianvincenzo Zuccotti
    Department of Paediatrics, Luigi Sacco Hospital, Universita di Milano, Milan, Italy
    BMC Infect Dis 10:218. 2010
  3. ncbi request reprint Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy
    Alessandro R Zanetti
    Istituto di Virologia, Universita degli Studi, Milano, Italy
    J Med Virol 70:27-30. 2003
  4. ncbi request reprint Safety and immunogenicity of influenza vaccination in individuals infected with HIV
    Alessandro R Zanetti
    Institute of Virology, University of Milan, Via Pascal 38, Milan 20133, Italy
    Vaccine 20:B29-32. 2002
  5. ncbi request reprint Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study
    Alessandro Remo Zanetti
    Istituto di Virologia, Universita di Milano, Milan, Italy
    Lancet 366:1379-84. 2005
  6. ncbi request reprint Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply
    Alessandro R Zanetti
    Department of Public Health Microbiology Virology, University of Milan, Italy
    J Clin Virol 36:S51-5. 2006
  7. doi request reprint The global impact of vaccination against hepatitis B: a historical overview
    Alessandro R Zanetti
    Department of Public Health Microbiology Virology, Faculty of Medicine, University of Milan, Via C Pascal 36, 20133 Milan, Italy
    Vaccine 26:6266-73. 2008
  8. doi request reprint Emerging and re-emerging infections at the turn of the millennium
    A R Zanetti
    Dipartimento di Sanità Pubblica Microbiologia Virologia, Universita degli Studi di Milano, Via C Pascal 36, 20133 Milan, Italy
    Haemophilia 16:7-12. 2010
  9. ncbi request reprint Update on hepatitis B vaccination in Italy 10 years after its implementation
    A R Zanetti
    Institute of Virology, University of Milan, Via C Pascal 38, 20133, Milan, Italy
    Vaccine 19:2380-3. 2001
  10. ncbi request reprint Mother-to-infant transmission of hepatitis C virus
    A R Zanetti
    Institute of Virology, University of Milan, Italy
    J Hepatol 31:96-100. 1999

Collaborators

Detail Information

Publications26

  1. doi request reprint Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy
    Alessandro Zanetti
    Dipartimento di Scienze Biomediche per la Salute, Universita degli Studi di Milano, Via Carlo Pascal, 36, 20133 Milano, Italy
    Vaccine 30:5770-5. 2012
    ..This study investigated responses to a challenge dose of monovalent hepatitis B vaccine in children immunised with three doses of either Hexavac or Infanrix-Hexa during infancy...
  2. pmc Epidemiological and clinical features of rotavirus among children younger than 5 years of age hospitalized with acute gastroenteritis in Northern Italy
    Gianvincenzo Zuccotti
    Department of Paediatrics, Luigi Sacco Hospital, Universita di Milano, Milan, Italy
    BMC Infect Dis 10:218. 2010
    ..Rotavirus is the major cause of acute gastroenteritis and severe dehydrating diarrhea in young children...
  3. ncbi request reprint Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy
    Alessandro R Zanetti
    Istituto di Virologia, Universita degli Studi, Milano, Italy
    J Med Virol 70:27-30. 2003
    ..In addition, with the advent of additional treatment protocols, a rapid, reliable assay for changes in HCV load may permit more frequent patient assessment and tailoring of the therapeutic regimen...
  4. ncbi request reprint Safety and immunogenicity of influenza vaccination in individuals infected with HIV
    Alessandro R Zanetti
    Institute of Virology, University of Milan, Via Pascal 38, Milan 20133, Italy
    Vaccine 20:B29-32. 2002
    ..Therefore, vaccination against influenza can be safely administered to HIV infected people...
  5. ncbi request reprint Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study
    Alessandro Remo Zanetti
    Istituto di Virologia, Universita di Milano, Milan, Italy
    Lancet 366:1379-84. 2005
    ..We undertook a multicentre study in previously vaccinated individuals to assess the duration of immunity and need for booster, over 10 years after vaccination...
  6. ncbi request reprint Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply
    Alessandro R Zanetti
    Department of Public Health Microbiology Virology, University of Milan, Italy
    J Clin Virol 36:S51-5. 2006
    ..There is agreement that, at present, the implementation of HBV DNA testing will not allow for discontinuation of screening for HBsAg...
  7. doi request reprint The global impact of vaccination against hepatitis B: a historical overview
    Alessandro R Zanetti
    Department of Public Health Microbiology Virology, Faculty of Medicine, University of Milan, Via C Pascal 36, 20133 Milan, Italy
    Vaccine 26:6266-73. 2008
    ..A future challenge is to overcome the social and economic hurdles which still hamper the introduction of hepatitis B vaccination on a global scale...
  8. doi request reprint Emerging and re-emerging infections at the turn of the millennium
    A R Zanetti
    Dipartimento di Sanità Pubblica Microbiologia Virologia, Universita degli Studi di Milano, Via C Pascal 36, 20133 Milan, Italy
    Haemophilia 16:7-12. 2010
    ..The end of the war against infectious diseases is not in sight. Mankind's battle with pathogens has lasted millennia and is destined to continue...
  9. ncbi request reprint Update on hepatitis B vaccination in Italy 10 years after its implementation
    A R Zanetti
    Institute of Virology, University of Milan, Via C Pascal 38, 20133, Milan, Italy
    Vaccine 19:2380-3. 2001
    ....
  10. ncbi request reprint Mother-to-infant transmission of hepatitis C virus
    A R Zanetti
    Institute of Virology, University of Milan, Italy
    J Hepatol 31:96-100. 1999
    ..Pregnancy is not contra-indicated in HCV-infected women. Without drugs to treat established infections in mothers and infants and interventions to prevent vertical transmission, routine HCV screening is not recommended in pregnant women...
  11. doi request reprint Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study
    Alessandro Remo Zanetti
    Department of Public Health Microbiology Virology, University of Milan, Milan, Italy
    Lancet Infect Dis 10:755-61. 2010
    ..In 2005, hexavac was suspended because of concerns about the long-term immunogenicity of its hepatitis B component. We aimed to assess the duration of immunity and need for booster injections in children primed with these vaccines...
  12. ncbi request reprint Primary prevention of hepatitis C virus infection
    Alessandro R Zanetti
    Institute of Virology, Faculty of Medicine, University of Milan, Milan, Italy
    Vaccine 21:692-5. 2003
    ..Health education, counselling and testing of individuals at risk provide opportunities for controlling HCV infection...
  13. ncbi request reprint Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users
    A Amendola
    Institute of Virology, University of Milan, Milan, Italy
    J Med Virol 65:644-8. 2001
    ..Immunization caused no significant changes in CD4+ counts and in neither plasma HIV-1 RNA nor proviral DNA levels. Therefore, vaccination against influenza may benefit persons infected by HIV-1...
  14. doi request reprint Hepatitis E: a puzzling double-faced disease
    L Romano
    Department of Biomedical Sciences for Health, University of Milan, Italy
    Ann Ig 25:169-80. 2013
    ..Two recently developed recombinant vaccines have proved to be safe and effective. One of such vaccines has recently been licensed for use in China...
  15. ncbi request reprint Decline in anti-HAV prevalence in the Milan area between 1958 and 1992
    A R Zanetti
    Institute of Virology, University of Milan, Italy
    Eur J Epidemiol 10:633-5. 1994
    ..The results show a dramatic reduction of HAV circulation likely due to the considerable improvement of socioeconomic and hygienic living conditions which have occurred in Italy during the last decades...
  16. ncbi request reprint Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users
    A Amendola
    Institute of Virology, University of Milan, Via Pascal 38, 20133, Milan, Italy
    Vaccine 20:3720-4. 2002
    ..Pneumococcal vaccination does not induce virological or immunological deterioration in HIV infected patients, but the antibody response to a single dose of vaccine is poor...
  17. ncbi request reprint Multicenter trial on mother-to-infant transmission of GBV-C virus. The Lombardy Study Group on Vertical/Perinatal Hepatitis Viruses Transmission
    A R Zanetti
    Institute of Virology, University of Milan, Italy
    J Med Virol 54:107-12. 1998
    ..The infection is transmitted efficiently from mother to baby and rate of transmission is much higher than that for HCV. GBV-C can cause persistent infection in babies but usually without clear evidence of liver disease...
  18. ncbi request reprint Identification of a novel variant of hepatitis E virus in Italy
    A R Zanetti
    Institute of Virology, University of Milan, Italy
    J Med Virol 57:356-60. 1999
    ..However, the identification of a new HEV variant in an individual who never indicated travel or contact with individuals associated with endemic areas, suggests that this virus may be native to Italy...
  19. ncbi request reprint GBV-C/hepatitis G virus in acute nonA-E hepatitis and in acute hepatitis of defined aetiology in Italy
    L Romano
    Institute of Virology, University of Milan, Milan, Italy
    J Med Virol 61:59-64. 2000
    ..Concomitant GBV-C/HGV and HBV or HCV infection does not worsen the clinical course of illness among patients with acute hepatitis...
  20. ncbi request reprint Safety and immunogenicity of a conjugate vaccine against Haemophilus influenzae type b in splenectomized and nonsplenectomized patients with Cooley anemia
    R Cimaz
    Clinica Pediatrica De Marchi, Istituti Clinici di Perfezionamento, 20122 Milan, Italy
    J Infect Dis 183:1819-21. 2001
    ..Hib conjugate vaccine is safe and immunogenic in patients with thalassemia major; however, additional studies are needed to assess the need and timing of booster vaccination to maintain long-term immunity...
  21. ncbi request reprint [Seroepidemiology of varicella in a cohort of Italian adolescents]
    L Romano
    Istituto di Virologia, Universita degli Studi di Milano
    Ann Ig 14:7-10. 2002
  22. ncbi request reprint Early co-circulation of different clades of influenza A/H1N1v pandemic virus in northern Italy
    E Pariani
    Department of Public Health Microbiology Virology, University of Milan, Italy
    J Prev Med Hyg 52:17-20. 2011
    ..About 45% of analyzed samples were laboratory-confirmed cases of A/HINlv. Sporadic cases occurred until the middle of June 2009, then, case numbers began to increase delineating distinct epidemiological phases of viral circulation...
  23. doi request reprint The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination
    Luisa Romano
    Department of Public Health Microbiology Virology, University of Milan, Via C Pascal 36, 20133 Milano, Italy
    Vaccine 27:3439-42. 2009
    ..An additional benefit of hepatitis B vaccination is that hepatitis Delta has also substantially declined...
  24. ncbi request reprint Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies
    Alberto Larghi
    Division of Internal Medicine, Department of Medicine, Surgery and Dentistry, Ospedale San Paolo, Italy
    Hepatology 36:993-1000. 2002
    ..In conclusion, our homogeneous cohort showed a wide spectrum of clinical, virologic and histologic features, and, more importantly, short-term outcome differed noticeably despite the common source of infection...
  25. doi request reprint Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey
    Claudio Velati
    Department of Transfusion Medicine and Haematology, Hospital of Sondrio, Sondrio, Italy
    Transfusion 48:2205-13. 2008
    ....
  26. ncbi request reprint Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth
    Maria Antonietta Casiraghi
    Liver Unit, Department of Medicine, Hospital of Legnano, Milan, Italy
    Hepatology 39:90-6. 2004
    ..In conclusion, taking into account the limited study sample, these findings suggest that HCV infection acquired early in life shows a slow progression and mild outcome during the first 35 yr of infection...